- Active not recruiting
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
This study looks at using a genetic test to help decide who needs prostate cancer screening. It uses a saliva sample to check for genetic differences that might increase your risk. If your risk is high, you might be offered further tests like an MRI scan and a biopsy.
For: Prostate CancerUnited Kingdom - Recruiting
The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
This study looks at a new saliva test, called i4i PRODICT®, to predict prostate cancer risk in men aged 40-55 from different ethnic backgrounds. It aims to see how well men accept and use this test.
For: Prostate CancerUnited Kingdom - Active not recruiting
The BARCODE 1 Pilot Study
This study looks at whether checking genes can help find men at higher risk of prostate cancer, so they can be offered special screening. It starts with 300 men to see if this genetic test works well for guiding check-ups.
For: Prostate CancerUnited Kingdom - Active not recruiting
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
The IMPACT study checks men with certain inherited gene changes (BRCA1, BRCA2, or Mismatch Repair genes) for prostate cancer. It also includes men without these changes. Researchers want to see if these gene changes increase prostate cancer risk and if screening helps.
For: Prostate Cancer · BRCA Mutation · Mismatch Repair Gene MutationUnited Kingdom